11 results on '"Stastna E"'
Search Results
2. Carbapenemase-producing Klebsiella pneumoniae in the Czech Republic in 2011
- Author
-
Hrabák, J., Papagiannitsis, C. C., Študentová, V., Jakubu, V., Fridrichová, M., Zemlickova, H., Adamkova, V., Bartonikova, N., Bartova, M., Bendova, E., Bergerova, T., Bohunova, Z., Capova, E., Chmelarova, E., Dovalova, M., Glasnak, M., Hanslianova, M., Haskova, V., Heinigeova, B., Hornikova, M., Horova, B., Janeckova, J., Jezek, P., Jindrak, V., Kolar, M., Kolarova, L., Kůrková, V., Linhart, P., Nedvedova, H., Niemczykova, J., Nyc, O., Petkov, V., Pokorna, Z., Pomykal, J., Puchalkova, B., Rumlerova, M., Ryskova, L., Scharfen, J., Sekacova, A., Skacaniova, H., Simeckova, E., Sosikova, M., Stastna, E., Steinerova, A., Stolbova, M., Tejkalova, R., Trojan, L., Typovska, H., Uhlirova, E., Vesela, E., Zalabska, E., Zamazalova, D., and Zaruba, R.
3. Clinical Evaluation of AMNIODERM+ ® Wound Dressing Containing Non-Viable Human Amniotic Membrane: Retrospective-Perspective Clinical Trial.
- Author
-
Schmiedova I, Slama P, Dembickaja A, Kozova B, Hyneckova V, Gogolkova S, Stastna E, Zahradnicek M, Savic S, Davani A, Hulo E, and Martinka E
- Abstract
Chronic wounds result from the body's inability to heal, causing pain, pathogen entry, limited treatment options, and societal burden. Diabetic foot ulcers are particularly challenging, often leading to severe complications like leg amputation. A clinical study tested AMNIODERM+
® , a new device with a lyophilized human amniotic membrane (HAM), on chronic diabetic foot ulcers. Participants had diabetic neuropathic or neuroischemic leg wounds (2-16 cm2 ) unhealed by 20% after six weeks of standard care. This study showed significant wound healing improvements with AMNIODERM+® . The median wound size reduction after 12 weeks was 95.5%, far exceeding the null hypothesis of 20% change. Additionally, 65% of patients achieved complete ulceration healing, surpassing the 50% efficacy requirement. The median time to full closure was 11.4 weeks, with the proportion of completely healed patients rising progressively, reaching 55% by week 11. These findings, from the clinical trial "Freeze-dried amniotic membrane in the treatment of nonhealing wounds", suggest AMNIODERM+® as a promising future treatment for chronic diabetic foot ulcers. The published results were obtained as part of a clinical trial entitled "Freeze-dried amniotic membrane in the treatment of nonhealing wounds: a single-arm, retrospectively-perspective clinical trial", EUDAMED Nr. CIV-SK-22-10-041146.- Published
- 2024
- Full Text
- View/download PDF
4. Case Report: Freeze-Dried Human Amniotic Membrane Allograft for the Treatment of Chronic Wounds: Results of a Multicentre Observational Study.
- Author
-
Schmiedova I, Ozanova Z, Stastna E, Kiselakova L, Lipovy B, and Forostyak S
- Abstract
An inability of the human body to heal acute wounds under certain conditions results in the formation of chronic ulcers. Chronic wounds not only cause significant pain and discomfort for patients but also serve as an entry for microorganisms into the human body, which can result in serious life-threatening problems and become a significant burden for the patients and society. The current work present results of a multicentre prospective observational study demonstrating the use of a lyophilized amniotic membrane (AM) in the treatment of chronic wounds (various etiologies). Lyophilized AM produced under the commercial brand Amnioderm® was used as an allograft material for therapy of chronic wounds, in addition to chronic ulcer standard-of-care (SoC) protocols. The duration of wounds considered for the application of AM ranged between 2 months and 11 years. In total, 16 patients were enrolled to the study, of which eight were completely healed, six demonstrated a significantly reduced ulcer size, and two did not respond to the AM therapy. The current study unambiguously demonstrates an effective alternative to the standard of chronic wound care and confirms a significant effect of the AM application for chronic wound management as a new SoC., Competing Interests: IS, ZO, ES, LK, and SF were employed by PrimeCell Bioscience Inc. IS, ZO, ES, LK, and SF were employed by Biohealing Inc. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Schmiedova, Ozanova, Stastna, Kiselakova, Lipovy and Forostyak.)
- Published
- 2021
- Full Text
- View/download PDF
5. Influence of Hydroxyapatite Nanoparticles and Surface Plasma Treatment on Bioactivity of Polycaprolactone Nanofibers.
- Author
-
Stastna E, Castkova K, and Rahel J
- Abstract
Nanofibers are well known as a beneficial type of structure for tissue engineering. As a result of the high acquisition cost of the natural polymers and their environmentally problematic treatment (toxic dissolution agents), artificial polymers seem to be the better choice for medical use. In the present study, polycaprolactone nano-sized fibrous structures were prepared by the electrospinning method. The impact of material morphology (random or parallelly oriented fibers versus continuous layer) and the presence of a fraction of hydroxyapatite nanoparticles on cell proliferation was tested. In addition, the effect of improving the material wettability by a low temperature argon discharge plasma treatment was evaluated, too. We have shown that both hydroxyapatite particles as well as plasma surface treatment are beneficial for the cell proliferation. The significant impact of both influences was evident during the first 48 h of the test: the hydroxyapatite particles in polycaprolactone fibers accelerated the proliferation by 10% compared to the control, and the plasma-treated ones enhanced proliferation by 30%.
- Published
- 2020
- Full Text
- View/download PDF
6. Structure-Properties Relationship of Electrospun PVDF Fibers.
- Author
-
Castkova K, Kastyl J, Sobola D, Petrus J, Stastna E, Riha D, and Tofel P
- Abstract
Electrospinning as a versatile technique producing nanofibers was employed to study the influence of the processing parameters and chemical and physical parameters of solutions on poly(vinylidene fluoride) (PVDF) fibers' morphology, crystallinity, phase composition and dielectric and piezoelectric characteristics. PVDF fibrous layers with nano- and micro-sized fiber diameters were prepared by a controlled and reliable electrospinning process. The fibers with diameters from 276 nm to 1392 nm were spun at a voltage of 25 kV-50 kV from the pure PVDF solutions or in the presence of a surfactant-Hexadecyltrimethylammonium bromide (CTAB). Although the presence of the CTAB decreased the fibers' diameter and increased the electroactive phase content, the piezoelectric performance of the PVDF material was evidently deteriorated. The maximum piezoelectric activity was achieved in the fibrous PVDF material without the use of the surfactant, when a piezoelectric charge of 33 pC N
-1 was measured in the transversal direction on a mean fiber diameter of 649 nm. In this direction, the material showed a higher piezoelectric activity than in the longitudinal direction.- Published
- 2020
- Full Text
- View/download PDF
7. Access of inhibitory neurosteroids to the NMDA receptor.
- Author
-
Borovska J, Vyklicky V, Stastna E, Kapras V, Slavikova B, Horak M, Chodounska H, and Vyklicky L Jr
- Subjects
- Action Potentials drug effects, Animals, Cell Membrane drug effects, Cell Membrane metabolism, Dose-Response Relationship, Drug, Excitatory Amino Acid Antagonists chemistry, HEK293 Cells, Humans, Microscopy, Fluorescence, Models, Molecular, Molecular Structure, Neurons drug effects, Neurons metabolism, Neuroprotective Agents chemistry, Neurotransmitter Agents chemistry, Pregnanes chemistry, Rats, Receptors, N-Methyl-D-Aspartate genetics, Structure-Activity Relationship, Transfection, Excitatory Amino Acid Antagonists pharmacology, Neuroprotective Agents pharmacology, Neurotransmitter Agents pharmacology, Pregnanes pharmacology, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors
- Abstract
Background and Purpose: NMDA receptors are glutamatergic ionotropic receptors involved in excitatory neurotransmission, synaptic plasticity and excitotoxic cell death. Many allosteric modulators can influence the activity of these receptors positively or negatively, with behavioural consequences. 20-Oxo-5β-pregnan-3α-yl sulphate (pregnanolone sulphate; PA-6) is an endogenous neurosteroid that inhibits NMDA receptors and is neuroprotective. We tested the hypothesis that the interaction of PA-6 with the plasma membrane is critical for its inhibitory effect at NMDA receptors., Experimental Approach: Electrophysiological recordings and live microscopy were performed on heterologous HEK293 cells expressing GluN1/GluN2B receptors and cultured rat hippocampal neurons., Key Results: Our experiments showed that the kinetics of the steroid inhibition were slow and not typical of drug-receptor interaction in an aqueous solution. In addition, the recovery from steroid inhibition was accelerated by β- and γ-cyclodextrin. Values of IC(50) assessed for novel synthetic C3 analogues of PA-6 differed by more than 30-fold and were positively correlated with the lipophilicity of the PA-6 analogues. Finally, the onset of inhibition induced by C3 analogues of PA-6 ranged from use-dependent to use-independent. The onset and offset of cell staining by fluorescent analogues of PA-6 were slower than those of steroid-induced inhibition of current responses mediated by NMDA receptors., Conclusion and Implications: We conclude that steroid accumulation in the plasma membrane is the route by which it accesses a binding site on the NMDA receptor. Thus, our results provide a possible structural framework for pharmacologically targeting the transmembrane domains of the receptor., (© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.)
- Published
- 2012
- Full Text
- View/download PDF
8. Synthesis of deuterium labeled NMDA receptor inhibitor - 20-Oxo-5β-[9,12,12-(2)H(3)]pregnan-3α-yl-L-glutamyl 1-ester.
- Author
-
Kapras V, Slavickova A, Stastna E, Vyklicky L Jr, Vales K, and Chodounska H
- Subjects
- Chromatography, Thin Layer, Hydroxyprogesterones chemistry, Isotope Labeling methods, Magnetic Resonance Spectroscopy, Molecular Structure, Oxidation-Reduction, Pregnanolone chemistry, Solvents chemistry, Deuterium chemistry, Glutamates chemistry, Pregnanolone analogs & derivatives, Pregnanolone chemical synthesis, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors
- Abstract
20-Oxo-5β-[9,12,12-(2)H(3)]pregnan-3α-yl-l-glutamyl 1-ester 11 was synthesized as an internal standard for quantification of a neuroprotective NMDA receptor ligand, 20-oxo-5β-pregnan-3α-yl-l-glutamyl 1-ester 18 and its metabolites, in plasma and tissue. 11α-Hydroxy-progesterone (1) was reduced under basic conditions to yield the corresponding 5β-steroid. Protection of the 3- and 20-oxo groups and oxidation of the 11α-hydroxy group was then followed by a deuterium exchange, conducted under basic conditions using deuterated methanol. Next, the carbonyl moiety at C-11 was reduced and the 11α-hydroxyl group removed through utilization of the Barton-McCombie reaction. Subsequent deprotection of the 3- and 20-acetals and stereoselective reduction of the 3-oxo group gave the desired trideuterated pregnanolone (8). This was coupled with protected glutamic acid, which was then deprotected to yield [9,12,12-(2)H(3)]-pregnanolone glutamate (11) with >99% isotopic purity., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
9. The use of symmetry in enantioselective synthesis: four pairs of chrysene enantiomers prepared from 19-nortestosterone.
- Author
-
Stastna E, Rath NP, and Covey DF
- Subjects
- Androgens chemistry, Chromatography, Thin Layer, Chrysenes analysis, GABA Agonists analysis, GABA Antagonists analysis, Humans, Magnetic Resonance Spectroscopy, Neurotransmitter Agents analysis, Pregnanes chemistry, Receptors, GABA metabolism, Stereoisomerism, Chemistry, Pharmaceutical methods, Chrysenes chemical synthesis, GABA Agonists chemical synthesis, GABA Antagonists chemical synthesis, Nandrolone chemistry, Neurotransmitter Agents chemical synthesis
- Abstract
Expansion of the D-ring of 19-norsteroids with incorporation of the steroid C-18 methyl group into a newly formed six-membered ring provides easy access to the chrysene ring system. By taking advantage of the symmetry of the chrysene ring system and avoiding meso chrysene intermediates, four optically pure 2,8-difunctionalized (C-2 hydroxyl group and C-8 oxo group) hexadecahydrochrysene diastereomers, and their corresponding optically pure enantiomers were prepared from 19-nortestosterone. The eight chrysene stereoisomers are of interest as starting materials for preparing chrysene analogues of physiologically important neurosteroids.
- Published
- 2011
- Full Text
- View/download PDF
10. Neurosteroid analogues. 16. A new explanation for the lack of anesthetic effects of δ(16)-alphaxalone and identification of a δ(17(20)) analogue with potent anesthetic activity.
- Author
-
Stastna E, Krishnan K, Manion BD, Taylor A, Rath NP, Chen ZW, Evers AS, Zorumski CF, Mennerick S, and Covey DF
- Subjects
- Anesthesia, Intravenous, Anesthetics administration & dosage, Anesthetics pharmacology, Animals, Larva drug effects, Mice, Molecular Structure, Oocytes drug effects, Oocytes physiology, Patch-Clamp Techniques, Pregnanediones administration & dosage, Pregnanediones pharmacology, Pregnenes administration & dosage, Pregnenes chemistry, Pregnenes pharmacology, Rats, Xenopus laevis, Anesthetics chemistry, Pregnanediones chemistry, Pregnenes chemical synthesis, Receptors, GABA-A metabolism
- Abstract
This study addresses the hypothesis that the lack of anesthetic activity for (3α,5α)-3-hydroxypregn-16-ene-11,20-dione (Δ(16)-alphaxalone) is explained by the steroid Δ(16) double bond constraining the steroid 20-carbonyl group to a position that prevents it from favorably interacting with γ-aminobutyric acid type A (GABA(A)) receptors. A series of Δ(16) and Δ(17(20)) analogues of Δ(16)-alphaxalone was prepared to evaluate this hypothesis in binding, electrophysiological, and tadpole anesthesia experiments. The results obtained failed to support the hypothesis. Instead, the results indicate that it is the presence of the C-21 methyl group in Δ(16)-alphaxalone, not the location of the constrained C-20 carbonyl group, that prevents Δ(16)-alphaxalone from interacting strongly with the GABA(A) receptor and having anesthetic activity. Consistent with this conclusion, a Δ(17(20)) analogue of Δ(16)-alphaxalone without a C-21 methyl group was found to be very similar to the anesthetic steroid (3α,5α)-3-hydroxypregnane-11,20-dione (alphaxalone) with regard to time of onset and rate of recovery from anesthesia when administered to mice by tail vein injection.
- Published
- 2011
- Full Text
- View/download PDF
11. Synthesis of C3, C5, and C7 pregnane derivatives and their effect on NMDA receptor responses in cultured rat hippocampal neurons.
- Author
-
Stastna E, Chodounska H, Pouzar V, Kapras V, Borovska J, Cais O, and Vyklicky L Jr
- Subjects
- Animals, Cells, Cultured, Electric Conductivity, Inhibitory Concentration 50, Neurons metabolism, Patch-Clamp Techniques, Pregnanes chemistry, Rats, Hippocampus cytology, Neurons drug effects, Pregnanes chemical synthesis, Pregnanes pharmacology, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors
- Abstract
The synthesis of several novel 5alpha- and 5beta-20-oxo-pregnane derivatives substituted in the position 3 and 7 of the steroid skeleton is described. Activity of synthesized compounds was studied in voltage-clamped cultured rat hippocampal neurons. Substituted derivatives inhibited NMDA-elicited neuronal activity. The relationship between biological activity and structure is discussed.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.